Flow cytometry instruments and services for cell analysis in research and clinical diagnostics
Cytek manufactures compact, affordable flow cytometry systems used in immunology, cancer research, and clinical diagnostics. The hiring mix—sales-heavy with distributed engineering, ops, and product—reflects a capital equipment company scaling field adoption and customer support. Active projects center on new product launches (Aurora CS, Orion), demo fleet management, and service contract operations, while supply chain constraints and service renewal friction appear as material operational drains.
Cytek Biosciences manufactures flow cytometry instruments and support services for researchers and clinicians worldwide. The technology enables rapid, single-cell analysis of tens of thousands of cells per second—far faster than traditional microscopy—making it central to cancer immunology, leukemia diagnosis, lymphoma detection, and minimal residual disease monitoring in transplant patients. The company operates across three business lines: instruments, reagents, and support services. With 501–1,000 employees headquartered in Fremont, CA, Cytek serves academic labs, hospital pathology departments, and biopharmaceutical R&D teams across the U.S., U.K., and continental Europe.
Compact, affordable flow cytometry instruments (Aurora CS, Orion models) paired with reagents and support services. Flow cytometry analyzes cellular characteristics at single-cell resolution across tens of thousands of cells per second for immunology, oncology, and clinical diagnostics.
Fremont, California. Privately held, 501–1,000 employees. Operates a global sales and support network spanning North America and Europe.
Other companies in the same industry, closest in size